Font Size: a A A
Keyword [EML4]
Result: 41 - 53 | Page: 3 of 3
41. Study On The Role Of EML4-ALK Regulating PD-L1 Expression In Non-small Cell Lung Cancer
42. Rediscovery Of The Target Of Famitnib And Correlation Study Of Its Metabolites With Efficacy And Adverse Reaction
43. Expression Of TGF ? R? Gene In Lung Adenocarcinoma With EML4-ALK Fusion Gene And Its Effect On The Biological Behavior Of Lung Adenocarcinoma Cells H3122
44. The Role Of Apatinib Reverses The Resistance Of Alectinib In EML4-ALK Positive Lung Cancer Cell Line H3122
45. The Relation Between EML4-ALK Fusion Gene Subtypes And Therapeutic Efficacy Of Advanced Non-small Cell Lung Cancer
46. Prognosis Of Surgically Resected Early-stage ALK-positive Lung Adenocarcinoma And Mechanism Of ALK Rearrangement Regulating PD-L1 Expression
47. Clinical And Imaging Features Of Cryptococcosis And ALK-postive NSCLC
48. Patholouical Results Of CT Guided Lung Biopsny Speimens And Surgical Specimens And Differences In Detection Of EGFR And ENIL4-ALK Fusion Genes And Its Clinical Significance
49. Clinical And Pathological Features Of Patients With EML4-ALK Fusion Gene Positive Non-small Cell Lung Cancer And The Curative Effect Of Crizotinib
50. Design,Synthesis And Biological Activity Evaluation Of ALK Inhibitors From Pyrrolopyrimidine And Thienopyrimidine Scaffolds
51. Clinical Significance And Biological Function Of Tyrosine Kinase Protein 7(PTK7) Expression In Non-small Cell Lung Cancer
52. Experimental Research Of Crizotinib And Tae684's Effects On Eml4-Alk-Positive Cell Line H2228
53. Comprehensive Analysis Of Clinical Pathological Features In Non-Small Cell Lung Cancer With EML4-ALK Fusion Gene Expression
  <<First  <Prev  Next>  Last>>  Jump to